AKR1C3 and cancer: As AKR1C3 is implicated in some hormone dependent malignancies and endocrine disorders, drugs selectively inhibiting AKR1C3 are investigated to be used as cancer treatment or drugs treating endocrine disorders for patients where this enzyme is overexpressed [33].